Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Lubov' Gavrilova"'
Autor:
Margarita Gurianova, Oleg Shukhov, Ekaterina Chelysheva, Anna Petrova, Anastasia Bykova, Irina Nemchenko, Elena Kuzmina, Lubov’ Gavrilova, Anna Turkina
Publikováno v:
HemaSphere, Vol 7, p e117994a (2023)
Externí odkaz:
https://doaj.org/article/acbf4cef4a63474f9ebae2a2617b2a67
Autor:
Valery G. Savchenko, Olga A. Gavrilina, Lubov Gavrilova, Gennadiy M. Galstyan, Alena Sukhareva, Alina Karpova, Ochsana Ochirova, Vasily Shuvaev, Anastasia N. Vasileva, Anton V. Luchkin, Olga Panteleeva, Kristina Zakurdaeva, Anzhelika F. Rakhmani, Mikhail A. Kunst, Tatiana V. Gaponova, Maria Grishunina, Olga Samoylova, Vera V. Troitskaya, Vladimir I. Vorobyev, Lev S. Butaev, Elena N. Parovichnikova
Publikováno v:
Blood
Background: Patients (pts) with hematologic disease are at increased risk of severe SARS-CoV-2 infection. Recent observations reported poor outcomes of COVID-19 in pts with various cancer types and higher mortality rates compared with the general pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ee41ba373b2424d0262c84c3308bf5
http://europepmc.org/articles/PMC8330244
http://europepmc.org/articles/PMC8330244
Autor:
Inessa Yu. Toropova, Tatiana V. Gaponova, Valery G. Savchenko, Andrei Petrenko, M. Popova, Yulia Sveshnikova, Maria Grishunina, Alina Karpova, Kaplanov Kd, Alena Sukhareva, Anastasia N. Vasileva, Lev S. Butaev, Vera V. Troitskaya, Dasha Baryshnikova, Vitaly S. Dubov, Ekaterina Chelysheva, Kristina Zakurdaeva, Vasily Shuvaev, Oksana Ochirova, Julia Chabaeva, Vladimir I. Vorobyev, Sergei Dubov, Lubov Gavrilova, Olga A. Gavrilina, Aleksander A. Siniaev
Publikováno v:
Blood
Background: Research on the impact of COVID-19 on different patient populations has been of great value for the optimization of patient care since the start of the SARS-CoV-2 pandemic. Earlier, we reported the interim analysis of the immediate outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0eb5ea718b51b4c77b1c0ec920d52b2
http://europepmc.org/articles/PMC8701609
http://europepmc.org/articles/PMC8701609
Autor:
Olga Senderova, Gysual Safuanova, Andrey Zaritsky, Elza Lomaia, Anton Kulikovsky, Elena Fedorova, Alexandr Korobkin, Marina Kozmina, Lubov Gavrilova, Eva Burnasheva, Elena Volodicheva, Galina Kuchma, Alexander S. Luchinin, Ludmila Napso, Dolgorzhap Dasheeva, Varvara I. Bakhtina, Ekaterina Chelysheva, Anna Lyamkina, Anton Shutilev, Marina Kosinova, Anatoly Golenkov, Vasilisa Skatova, Olga V. Lazareva, Svetlana Volkova, Sergei M. Kulikov, Tatiana Konstantinova, Sergey Voloshin, Vera Yablokova, Tatiana Klitochenko, Anna G. Turkina, Andrew Proidakov, Nataliya Glonina, Andrew Zhuravkov, Tatiana Chagorova, Olga Vinogradova
Publikováno v:
Blood. 138:5035-5035
The results of long-term follow-up of patients (pts) with chronic myeloid leukemia (CML) do not lose their importance. Data from routine clinical practice are of particular interest. The use of 1 st (imatinib, IM) and 2nd generation TKI (2G TKI) led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a19128c61306200bf830a0b28868e780
https://doi.org/10.1182/blood-2021-151371
https://doi.org/10.1182/blood-2021-151371
Autor:
Sergey Dubov, Valery G. Savchenko, Lev S. Butaev, Hunan Julhakyan, Yulia Sveshnikova, Inessa Yu. Toropova, Oksana Ochirova, Olga A. Gavrilina, E A Gilyazitdinova, Aleksandr A. Siniaev, Vasily Shuvaev, Anastasia N. Vasileva, Lubov Gavrilova, Maria Grishunina, Kristina Zakurdaeva, Mikhail A. Kunst, Marina O. Popova, Vladimir I. Vorobyev, K D Kaplanov, Al'-Radi Ls, Andrei Petrenko, Yulia A. Chabaeva, Daria Baryshnikova, Vitaly S. Dubov
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia
Background Patients (pts) with lymphoproliferative diseases (LPD) are at high risk of COVID-19 severe and lethal course. Objective To evaluate treatment outcomes and risk factors in pts with LPD and COVID-19 in a real-world setting. Methods CHRONOS19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac386586f20ac7457204c2d72791da1
http://europepmc.org/articles/PMC8404062
http://europepmc.org/articles/PMC8404062
Autor:
Oksana Ochirova, Olga A. Gavrilina, Aleksandr A. Siniaev, Anastasia N. Vasileva, Yulia Sveshnikova, Sergei Dubov, Yulia A. Chabaeva, Marina O. Popova, Lev S. Butaev, Kaplanov Kd, Anzhelika F. Rakhmani, Inessa Yu. Toropova, Vitaly S. Dubov, Lubov Gavrilova, Mikhail A. Kunst, Alena Sukhareva, Valery G. Savchenko, Andrei Petrenko, Ekaterina Chelysheva, Kristina Zakurdaeva
Publikováno v:
Journal of Clinical Oncology. 39:e18715-e18715
e18715 Background: Pts with hem diseases are at high risk of COVID-19 severe course and mortality. Emerging data on risk factors and outcomes in this patient population is of great value for developing strategies of medical care. Methods: CHRONOS19 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::854a5d881e14c33970ac5bd8c79d4382
https://doi.org/10.1200/jco.2021.39.15_suppl.e18715
https://doi.org/10.1200/jco.2021.39.15_suppl.e18715
Autor:
Hunan Julhakyan, Galina I. Milutina, Oleg Shukhov, Lubov Gavrilova, Valentina Pepeliaeva, Olga Vinogradova, Alexander S. Luchinin, Anton Kulikovskiy, Lubov Avdeeva, Maria V. Galayko, Sergey Meresiy, Ekaterina Chelysheva, Olga Senderova, Sergey M. Kulikov, Anna G. Turkina, Elena B. Dasheeva, Olga V. Lazareva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S298-S299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2fbbb5ad4ea2509e119b9f505c82492
https://doi.org/10.1016/j.clml.2019.07.252
https://doi.org/10.1016/j.clml.2019.07.252
Autor:
Galina I. Milutina, Ekaterina Chelysheva, Sergei M. Kulikov, Valentina Pepeliaeva, L B Avdeeva, Anton Kulikovsky, Lubov Gavrilova, Olga Vinogradova, Sergey Meresiy, Dolgorzhap Dasheeva, Olga V. Lazareva, Alexander S. Luchinin, Anna G. Turkina, Olga Senderova
Publikováno v:
Blood. 134:5902-5902
Background: A success of the tyrosine kinase inhibitors (TKI) therapy in patients (pts) with chronic myeloid leukemia (CML) allowed to set a new goal: a treatment-free remission (TFR). A stable and long-lasting deep molecular response (DMR) is requir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5b90d338bacb27a4741ee02bea1b161
https://doi.org/10.1182/blood-2019-131430
https://doi.org/10.1182/blood-2019-131430
Autor:
Lubov Gavrilova, Alexander S. Luchinin, Olga Senderova, Vanik A. Ovsepyan, Marya V. Galayko, Sergey V. Meresy, Valentyna M. Pepelyaeva, Sergey M. Kulikov, Galina I. Milutina, Irina A. Titshenko, L B Avdeeva, Olga Vinogradova, Ekaterina Chelysheva, Eduard G. Gendgan, Anna G. Turkina
Publikováno v:
Blood. 120:4431-4431
Abstract 4431 The European Treatment Outcome Study (EUTOS) is register based international investigation started in June 2007. [1] The aim is to study the epidemiology of CML and to gain insight into the ‘real world’ treatment of patients with CM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d7cc52958966cd62f42d7247eb16de7
https://doi.org/10.1182/blood.v120.21.4431.4431
https://doi.org/10.1182/blood.v120.21.4431.4431
Autor:
Gavrilina, Olga, Zakurdaeva, Kristina, Vasileva, Anastasia, Vorobyev, Vladimir, Butaev, Lev, Dubov, Vitaly, Dubov, Sergey, Toropova, Inessa, Gavrilova, Lubov, Popova, Marina, Siniaev, Aleksandr, Kaplanov, Kamil, Petrenko, Andrei, Ochirova, Oksana, Sveshnikova, Yulia, Shuvaev, Vasily, Grishunina, Maria, Kunst, Mikhail, Chabaeva, Yulia, Al-Radi, Lyubov
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS243-S243, 1p